DOCK5 and focal segmental glomerulosclerosis: Similar to DKD, Dock5 cKO mice under FSGS conditions (ADR‐treated) showed higher KW/BW and UACR, exacerbated glomerular pathology, aggravated thickening of GBM, podocyte foot process broadening and effacement, and podocyte loss (Figure 3L–P).